NDC 58264-0002

D2

Gold Trichloride, Crataegus Laevigata Whole, Selenicereus Grandiflorus Whole, Dibasic Potassium Phosphate, Aconitum Napellus, Valeriana Officinalis Whole, Spigelia Anthelmia, Arnica Montana, Digitalis Purpurea Whole, Prunus Laurocerasus Whole, And Strychnos Ignatii Whole

D2 is a Sublingual Solution in the Human Otc Drug category. It is labeled and distributed by Dna Labs, Inc.. The primary component is Gold Trichloride; Crataegus Laevigata Whole; Selenicereus Grandiflorus Whole; Dibasic Potassium Phosphate; Aconitum Napellus; Valeriana Officinalis Whole; Spigelia Anthelmia; Arnica Montana; Digitalis Purpurea Whole; Prunus Laurocerasus Whole; Strychnos Ignatii Whole.

Product ID58264-0002_908e4ffc-c159-41ba-97ff-5e972fb82195
NDC58264-0002
Product TypeHuman Otc Drug
Proprietary NameD2
Generic NameGold Trichloride, Crataegus Laevigata Whole, Selenicereus Grandiflorus Whole, Dibasic Potassium Phosphate, Aconitum Napellus, Valeriana Officinalis Whole, Spigelia Anthelmia, Arnica Montana, Digitalis Purpurea Whole, Prunus Laurocerasus Whole, And Strychnos Ignatii Whole
Dosage FormSolution
Route of AdministrationSUBLINGUAL
Marketing Start Date1990-01-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDNA Labs, Inc.
Substance NameGOLD TRICHLORIDE; CRATAEGUS LAEVIGATA WHOLE; SELENICEREUS GRANDIFLORUS WHOLE; DIBASIC POTASSIUM PHOSPHATE; ACONITUM NAPELLUS; VALERIANA OFFICINALIS WHOLE; SPIGELIA ANTHELMIA; ARNICA MONTANA; DIGITALIS PURPUREA WHOLE; PRUNUS LAUROCERASUS WHOLE; STRYCHNOS IGNATII WHOLE
Active Ingredient Strength6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 58264-0002-1

29.57 mL in 1 BOTTLE, GLASS (58264-0002-1)
Marketing Start Date1990-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58264-0002-1 [58264000201]

D2 SOLUTION
Marketing CategoryUNAPPROVED HOMEOPATHIC
Product TypeHUMAN OTC DRUG
Marketing Start Date1990-01-01
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.